Farther Finance Advisors, LLC

Position in LLY — ELI LILLY & Co

CIK 1992825 SAN FRANCISCO, CA

Position in LLY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$52,545,833

+$13,737,058 QoQ

Shares Held

43,809

+3.8% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

1.25%

of 13F equity value

Holder Rank

#121

of 2,003 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $187,005,351 across 18 Drug Manufacturers - General names. LLY ranks #1 (28.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	43,809	$52,545,833
2	JNJ	Johnson & Johnson	135,612	$34,441,379
3	ABBV	AbbVie Inc.	119,959	$30,186,482
4	MRK	Merck & Co., Inc.	120,685	$15,508,022
5	AMGN	Amgen Inc	34,711	$12,569,547
6	PFE	Pfizer Inc	395,297	$9,518,751
7	BMY	Bristol Myers Squibb Co	148,017	$8,528,739
8	GILD	Gilead Sciences, Inc.	58,478	$7,388,110

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$52,545,833	43,809	+3.8%	Shares	Sole	2026-07-17
2026-03-31	$38,808,775	42,194	+35.5%	Shares	Sole	2026-04-07
2025-12-31	$33,470,911	31,145	+30.8%	Shares	Sole	2026-01-23
2025-09-30	$18,164,741	23,807	+1.3%	Shares	Sole	2025-10-14
2025-06-30	$18,315,057	23,495	+31.8%	Shares	Sole	2025-07-11
2025-03-31	$14,721,845	17,825	+26.2%	Shares	Sole	2025-04-14
2024-12-31	$10,904,500	14,125	+1.1%	Shares	Sole	2025-02-10
2024-09-30	$12,379,239	13,973	+12.2%	Shares	Sole	2024-10-29
2024-06-30	$11,274,697	12,453	+50.1%	Shares	Sole	2024-07-31
2024-03-31	$6,453,956	8,296	+8.5%	Shares	Sole	2024-05-14
2023-12-31	$4,455,840	7,644	+44.4%	Shares	Sole	2024-02-15
2023-09-30	$2,843,566	5,294	+49.1%	Shares	Sole	2023-11-14
2023-06-30	$1,665,347	3,551	+385.1%	Shares	Sole	2024-05-14
2023-03-31	$251,383	732	-6.4%	Shares	Sole	2024-05-14
2022-12-31	$286,086	782	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.